News

Happy ending after long ordeal

Ventricular assist device saves four-year-old’s life / MHH doctors bridge gap until transplantation / Success for Department of Paediatrics’ centre for people with congenital heart disease Nina is laughing and playing happily,... [more]

ARISE clinical study presented at the 31st Annual Meeting of the European Association For Cardio-Thoracic Surgery (EACTS) 2017 in Vienna

Brazilian group reports results of decellularised allografts used for RVOT construction during the ROSS operation Training workshop for young surgeons held in Barcelona in November 2017 Prof. Dr. Samir Sarikouch presented the... [more]

ARISE Clinical Trial half-time on the road

Patient inclusion to the ARISE trial is proceeding nicely. Figure 1 is showing the numbers of patients operated within the trial already as well as the number of scheduled operations. Therefore the ARISE consortium is confident... [more]

Welcome to ARISE

65,000 aortic valve replacements (AVR) are performed in Europe each year to treat acquired and congenital aortic valve diseases. Current AVR options are, however, limited for young patients - especially female patients - and those unwilling to accept life-long medical anticoagulation with its inherent risks. None of the currently available prostheses for AVR is tailored toward the individual patient or allows for individual regeneration. The ARISE project will bridge this therapeutic gap in a clinical study to determine the feasibility, safety and efficacy of regenerative heart valves for aortic valve replacement.